英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：

spareness    
n. 缺乏,贫乏,瘦弱

缺乏,贫乏,瘦弱

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Greenwich LifeSciences, Inc. (GLSI) | GP2
    Greenwich LifeSciences, Inc is a clinical-stage biopharmaceutical company focused on the development of an immunotherapy, GP2, to prevent breast cancer recurrences in patients who have previously undergone surgery
  • Company Information | Greenwich LifeSciences, Inc. (GLSI) | GP2
    Company Profile Business Description: Greenwich LifeSciences (the “Company”) is a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery
  • Leadership | Greenwich LifeSciences, Inc. (GLSI) | GP2
    The Greenwich LifeSciences’ leadership is dedicated to discovering and developing biotherapeutics that advance patient care
  • Greenwich LifeSciences Announces Positive Immune Response Data from . . .
    STAFFORD, Texas, April 02, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today announced the following update on FLAMINGO-01 open label immune response data FLAMINGO-01
  • Investors Media | Greenwich LifeSciences, Inc. (GLSI) | GP2
    Business Description: Greenwich LifeSciences (the “Company”) is a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone…
  • Greenwich LifeSciences Announces Addition of City of Hope to FLAMINGO-01
    About Greenwich LifeSciences, Inc Greenwich LifeSciences is a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery
  • Greenwich LifeSciences Hires Industry Expert, Dr. Jaye Thompson, to . . .
    Greenwich LifeSciences is a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery GP2 is a 9 amino acid transmembrane peptide of the HER2 neu protein
  • Greenwich LifeSciences, Inc. to Participate at Upcoming Investor and . . .
    About Greenwich LifeSciences, Inc Greenwich LifeSciences is a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery
  • Greenwich LifeSciences Announces Preliminary Analysis Showing 80% . . .
    STAFFORD, Texas, Dec 15, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today announced an approximately 80% recurrence rate reduction in the open label non-HLA-A*02 arm of
  • Greenwich LifeSciences Partners with GEICAM in Spain Conducts First . . .
    About Greenwich LifeSciences, Inc Greenwich LifeSciences is a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery





中文字典-英文字典  2005-2009